Establishment Labs (ESTA) Projected to Post Quarterly Earnings on Wednesday

Establishment Labs (NASDAQ:ESTA - Get Free Report) is expected to announce its Q1 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect Establishment Labs to post earnings of ($0.83) per share and revenue of $41.15 million for the quarter.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The company had revenue of $44.51 million during the quarter, compared to analysts' expectations of $44.45 million. On average, analysts expect Establishment Labs to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Establishment Labs Trading Up 0.4 %

Shares of ESTA traded up $0.13 during midday trading on Monday, hitting $33.52. The stock had a trading volume of 557,056 shares, compared to its average volume of 461,986. The stock's 50 day moving average is $35.67 and its 200 day moving average is $38.83. Establishment Labs has a 1 year low of $26.56 and a 1 year high of $60.12. The firm has a market cap of $966.92 million, a PE ratio of -12.99 and a beta of 0.73. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ESTA. Stephens reaffirmed an "overweight" rating and set a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. Needham & Company LLC started coverage on Establishment Labs in a report on Monday, April 14th. They set a "hold" rating for the company. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $57.40.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.